Four days left to vote for the top nephrology story of 2013. So far, the top 3 are:
For a round up of pieces promoting various stories in this and other blogs:
- The CORAL Trial
- The Nephron-D Trial
- JASN paper showing improved mortality for online HDF compared with standard HD.
For a round up of pieces promoting various stories in this and other blogs:
- My own take on KIM1 and a piece on the uselessness of urinary eosinophils
- Andrew on UMOD, new targets for PKD and the new cholesterol guidelines
- Paul on Rituximab for ANCA-associated vasculitis
- Edgar on Nephron D at eAJKD
- Matt on APOL1 also at eAJKD
- Kenar at Nephron Power on Abatacept for FSGS
- Ed El Sayed at PBF also on Nephron D
- Joel on Tolvaptan in PKD at PBF
- Christos on HDPAL also at PBF
- Adrian on 23andMe at Red Beans
- Pascale on 23andMe at WhizBANG
No comments:
Post a Comment